Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Net Income towards Common Stockholders (2021 - 2025)

Historic Net Income towards Common Stockholders for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to -$1.7 million.

  • Cardio Diagnostics Holdings' Net Income towards Common Stockholders fell 2137.74% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.6 million, marking a year-over-year increase of 2061.01%. This contributed to the annual value of -$8.4 million for FY2024, which is 7.9% down from last year.
  • Per Cardio Diagnostics Holdings' latest filing, its Net Income towards Common Stockholders stood at -$1.7 million for Q3 2025, which was down 2137.74% from -$1.7 million recorded in Q2 2025.
  • In the past 5 years, Cardio Diagnostics Holdings' Net Income towards Common Stockholders registered a high of -$397.0 during Q2 2021, and its lowest value of -$4.2 million during Q1 2024.
  • Over the past 5 years, Cardio Diagnostics Holdings' median Net Income towards Common Stockholders value was -$1.4 million (recorded in 2023), while the average stood at -$1.5 million.
  • As far as peak fluctuations go, Cardio Diagnostics Holdings' Net Income towards Common Stockholders plummeted by 21199017.63% in 2022, and later soared by 6798.35% in 2024.
  • Over the past 5 years, Cardio Diagnostics Holdings' Net Income towards Common Stockholders (Quarter) stood at -$144837.0 in 2021, then tumbled by 1541.89% to -$2.4 million in 2022, then skyrocketed by 41.59% to -$1.4 million in 2023, then fell by 9.39% to -$1.5 million in 2024, then decreased by 12.85% to -$1.7 million in 2025.
  • Its last three reported values are -$1.7 million in Q3 2025, -$1.7 million for Q2 2025, and -$1.6 million during Q1 2025.